FASENRA 30 mg/mL (Benralizumab INJECTION, SOLUTION) 30 mg/mL

FASENRA 30 mg/mL is a subcutaneous injection solution containing benralizumab. This medication is used to manage specific respiratory conditions, offering targeted therapy for improved symptom control. Learn more about its uses and effects.

Strength

30 mg/mL

Pack Size

1 CARTRIDGE in 1 CARTON (0310-1830-85) / 1 mL in 1 CARTRIDGE

Manufacturer / TM Owner

AstraZeneca Pharmaceuticals LP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

FASENRA 30 mg/mL is primarily used for the maintenance treatment of certain respiratory conditions. It works by targeting specific cells involved in inflammation, helping to reduce symptoms and improve quality of life. Patients often wonder, 'What is FASENRA used for?' This medication is designed to provide long-term management for those with qualifying conditions.

Side Effects

Common effects of FASENRA 30 mg/mL may include reactions at the injection site, such as redness or itching. Some users might experience headaches or fatigue. These effects vary among individuals and typically subside over time. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

FASENRA 30 mg/mL should be handled with care, ensuring proper storage and administration. It is important to follow healthcare provider instructions for use. Patients with known allergies to benralizumab or any of the ingredients should avoid this medication. Always inform your healthcare provider about your medical history before starting treatment.

Avoid Interactions

FASENRA 30 mg/mL may interact with other medications, including those that affect the immune system. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain foods may also impact the effectiveness of this medication.

Frequently Asked Questions

FASENRA 30 mg/mL is used for the maintenance treatment of specific respiratory conditions, helping to manage symptoms and improve quality of life.

FASENRA 30 mg/mL is administered via subcutaneous injection, typically self-administered or by a healthcare provider.

Common side effects may include injection site reactions, headaches, and fatigue. These effects vary among individuals.

FASENRA may interact with other medications, so it is important to discuss all current medications with a healthcare provider.

FASENRA should be stored as per the instructions provided, typically in a cool, dry place away from direct sunlight.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.